Headlines

CELG

Hot News : U.S. Bancorp (NYSE:USB), Celgene Corporation (NASDAQ:CELG), Education Management Corporation (NASDAQ:EDMC), FleetCor Technologies, Inc. (NYSE:FLT), Novartis AG (NYSE:NVS)

Jason Knox03 mins

On Oct 22, U.S. Bancorp (NYSE:USB) reported a slight increase in third-quarter profit as its revenue rose and it posted loan growth. The results were in line with analysts’ expectations. The Minneapolis-based bank said it earned a little more than $1.47 billion in the quarter, up from just under $1.47 billion a year earlier. On…

Read More

Eye Catching Stocks : Celgene Corporation (NASDAQ:CELG), Bankrate, Inc. (NYSE:RATE), China Ming Yang Wind Power Group Limited (NYSE:MY), GILD, AxoGen, Inc. (NASDAQ:AXGN)

Colin Pettis03 mins

On Oct 20, Sequenta, Inc., announced an equity investment by Celgene Corporation (NASDAQ:CELG) and other strategic investors. This financing, in addition to funding secured from several other strategic investors, will support incorporation of the ClonoSIGHT™ minimal residual disease (MRD) test into clinical trials of medicines in development for various hematological malignancies (blood cancers) and development…

Read More

Worth Watching Stocks : RF Micro Devices (NASDAQ:RFMD), Celgene (NASDAQ:CELG), RigNet, Inc. (NASDAQ:RNET), AK Steel Holding Corporation (NYSE:AKS), Power Integrations Inc. (NASDAQ:POWI)

Jayne Crisman03 mins

RF Micro Devices Inc. (NASDAQ:RFMD) has been on the move lately as the stock has risen by 18.7% in the past four weeks, and it is currently trading well above its 20-Day SMA. While there can be no telling for sure, it is certainly encouraging that earnings estimates have risen in the past few weeks on…

Read More

Healthcare ACtive Runners: Teva Pharmaceutical Industries (NYSE:TEVA), Exelixis (NASDAQ:EXEL), Novavax (NASDAQ:NVAX), Abbott Laboratories (NYSE:ABT), Celgene (NASDAQ:CELG)

Jason Knox03 mins

Just a month ago, Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) snapped up portfolio company, San Mateo, CA-based Labrys Biologics, for $200 million up front and another $625 million in milestones. That deal came less than two years after Labrys was formed, and venBio partner and co-founder Corey Goodman told Xconomy at the time that venBio had contributed $8.5…

Read More

Biotech New Highs: Celgene Corporation (NASDAQ:CELG), Omeros Corporation (NASDAQ:OMER), Repligen Corporation (NASDAQ:RGEN), Pain Therapeutics, Inc. (NASDAQ:PTIE)

Richard Atkins02 mins

Celgene Corporation (NASDAQ:CELG)’s stock had its “outperform” rating restated by Credit Suisse in a research note issued on Thursday. They currently have a $225.00 price target on the stock, up from their previous price target of $210.00. Credit Suisse’s target price would suggest a potential upside of 31.23% from the company’s current price. Celgene Corporation…

Read More

Biotech Active Stocks: Celgene Corporation (NASDAQ:CELG), Arena Pharmaceuticals (NASDAQ:ARNA), Cell Therapeutics (NASDAQ:CTIC), Inovio Pharmaceuticals (NYSEMKT:INO)

John Meady02 mins

U.S. health regulators on Friday approved a Celgene Corporation (NASDAQ:CELG) drug to treat psoriatic arthritis, a type of arthritis associated with the skin disease psoriasis that causes joint pain, stiffness and swelling. Celgene Corporation (NASDAQ:CELG) stock performance was -3.74% in last session and finished the day at $144.40. Traded volume was 9.50million shares in the…

Read More
Home